These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7729465)

  • 21. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of antibiotic resistance and resistance mechanisms. Foreword.
    Bonomo RA; Rossolini GM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
    [No Abstract]   [Full Text] [Related]  

  • 23. Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control.
    Nelson RR
    J Hosp Infect; 1999 Aug; 42(4):275-82. PubMed ID: 10467540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
    Johnson AP; Mushtaq S; Warner M; Livermore DM
    Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens.
    Apparao D; Oliveira L; Ruegg PL
    J Am Vet Med Assoc; 2009 Jun; 234(11):1437-46. PubMed ID: 19480625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Linezolid, an agent from a new class of antibiotics].
    Kuijper EJ; Schippers EF; Bernards AT
    Ned Tijdschr Geneeskd; 2004 Aug; 148(32):1577-81. PubMed ID: 15382556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
    Appelbaum PC; Jacobs MR
    Curr Opin Microbiol; 2005 Oct; 8(5):510-7. PubMed ID: 16098786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.
    Pea F; Viale P
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):255-70. PubMed ID: 17402840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gram-positives towards the year 2000.
    Moellering RC
    Drugs; 1997; 54 Suppl 6():1-3. PubMed ID: 9474475
    [No Abstract]   [Full Text] [Related]  

  • 30. [Resistance to antibiotics in gram-positive bacteria from blood cultures].
    Jensen KT; Scheel O
    Ugeskr Laeger; 1988 Dec; 150(49):3056-8. PubMed ID: 3201627
    [No Abstract]   [Full Text] [Related]  

  • 31. [New gram-positive opportunistic bacteria: pathogenic role and treatment].
    Philippon A; Barbut F
    Presse Med; 1997 May; 26(16):778-86. PubMed ID: 9205480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New mechanism for detection of infections using the innate immune system of animals].
    Ferrandon D; Gottar M; Gobert V
    Med Sci (Paris); 2007; 23(8-9):707-9. PubMed ID: 17875288
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prospects of development of drugs for therapy of gram-positive bacterial infections].
    Sidorenko SV
    Antibiot Khimioter; 2000; 45(10):3-4. PubMed ID: 11212398
    [No Abstract]   [Full Text] [Related]  

  • 34. Gram-positive bacterial resistance: future treatment options.
    Bassetti M; Melica G; Di Biagio A; Rosso R; Gatti G; Bassetti D
    Curr Opin Investig Drugs; 2003 Aug; 4(8):944-52. PubMed ID: 14508878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
    Chien JW; Kucia ML; Salata RA
    Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New infective problems with old gram-positive pathogens: setting the stage.
    Sanders WE
    Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S1-2. PubMed ID: 7729465
    [No Abstract]   [Full Text] [Related]  

  • 38. Fighting infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G
    Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.